Unraveling the molecular mechanism of nitrosative stress resistance in tuberculo...
Unraveling the molecular mechanism of nitrosative stress resistance in tuberculosis
Tuberculosis is today amongst the major worldwide health threats. Treatment failure is unfortunately becoming more usual, especially in countries lacking the long and costly treatment adapted to patients. Thus, tuberculosis causes...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2008-05595-C02-01
BASES DEL MECANISMO MOLECULAR DE RESISTENCIA A ESTRES NITROS...
145K€
Cerrado
ECOEVODRTB
Linking within host and between host evolution of multidrug...
3M€
Cerrado
TARGID
Host target identification of anti virulence drugs
193K€
Cerrado
COMBATTB
Comprehensive Mechanisms of Bacterial Antibiotic Tolerance i...
213K€
Cerrado
NovAnI
Indentification and optimisation of novel anti infective age...
1M€
Cerrado
PID2021-123829NA-I00
EVOLUCION DIRIGIDA DEL RIBOSOMA DE MICOBACTERIAS BAJO PRESIO...
182K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Tuberculosis is today amongst the major worldwide health threats. Treatment failure is unfortunately becoming more usual, especially in countries lacking the long and costly treatment adapted to patients. Thus, tuberculosis causes 2 million deaths every year and latently persists in over 1 billion individuals worldwide. Current treatments are challenged by multidrug resistant strains, drug side effects, and co-infections. Therefore, identification of potent, safety antimycobacterial agents is mandatory. However, the success of this strategy is largely determined by the detailed knowledge of their mechanism of action, which in turn depends on the validation of suitable biological targets. This project pursues the definition of new, complementary therapeutic approaches by identifying the molecular basis of the nitrosative stress resistance of M. tuberculosis. Our working hypothesis is that a decrease in the NO resistance of the microorganism should reduce significantly the capability to rest in latency, thus contributing to increase the efficacy of the therapeutic treatment. In this context, understanding of the NO detoxification activity played by M. tuberculosis trHbN is essential. Accordingly, our objectives are i) to unravel the molecular mechanism underlying the NO dioxygenase activity of M. tuberculosis trHbN, ii) to establish the structure-function relationships in trHbN and trHbO from M. tuberculosis, and iii) to identify the reductase protein system that helps trHbN to restore the ferrous state required to initiate the NO detoxification cycle. The outcome of the project should provide a firm basis to assess the viability of trHbN as a therapeutic target, and set up the background to exploit this knowledge in the design of innovative therapeutic strategies to fight the disease.